Viewing Study NCT01085266


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2026-01-29 @ 4:51 PM
Study NCT ID: NCT01085266
Status: TERMINATED
Last Update Posted: 2016-10-12
First Post: 2010-03-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Sponsor:
Organization: